Russell Falkenstein - Sep 13, 2023 Form 3 Insider Report for Aaron's Company, Inc. (AAN)

Role
EVP, COO, Lease-to-Own
Signature
/s/ Douglass L. Noe, by Power of Attorney for Russell Falkenstein
Stock symbol
AAN
Transactions as of
Sep 13, 2023
Transactions value $
$0
Form type
3
Date filed
9/21/2023, 04:30 PM
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AAN Common Stock 32.8K Sep 13, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AAN Stock Options (Right to Buy) Sep 13, 2023 Common Stock 3.56K $13.67 Direct F1
holding AAN Stock Options (Right to Buy) Sep 13, 2023 Common Stock 4.46K $15.67 Direct F2
holding AAN Stock Options (Right to Buy) Sep 13, 2023 Common Stock 11.3K $12.35 Direct F3
holding AAN Stock Options (Right to Buy) Sep 13, 2023 Common Stock 9.36K $21.76 Direct F4
holding AAN Stock Options (Right to Buy) Sep 13, 2023 Common Stock 6.75K $21.45 Direct F5
holding AAN Stock Options (Right to Buy) Sep 13, 2023 Common Stock 12.7K $12.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vested on March 7, 2021.
F2 These options vested on March 7, 2022.
F3 These options vested on March 7, 2023.
F4 One third of these options vested on March 7, 2022, with another third that vested on March 7, 2023. The remaining one third of these options are expected to vest on March 7, 2024, subject to the grant agreement between the Issuer and the Reporting Person.
F5 One third of these options vested on March 7, 2023. The remaining two thirds of these options are expected to vest in two equal increments on each of March 7, 2024 and 2025, subject to the grant agreement between the Issuer and the Reporting Person.
F6 These options are expected to vest in three equal increments on each of March 7, 2024, 2025 and 2026, subject to the grant agreement between the Issuer and the Reporting Person.